ORIGINAL_ARTICLE
Isolation and characterization of curcumin from powdered rhizomes of turmeric plant marketed in Maragheh city of Iran with soxhlet technique
Turmeric (Curcuma longa L.) is extensively used as a spice, food preservative and colouring material. It has been used in traditional medicine for various diseases. Curcumin, the main yellow bioactive component of turmeric has been shown to have a wide spectrum of biological actions. Heretofore, it has been reported that natural colored extracts isolated from turmeric rhizomes with many methods such as maceration, digestion, microwave and infusion. In this paper, it was tried to isolate and characterize curcumin from the curcumin rhizomes marketed in Maragheh city of Iran by soxhlet extraction technique in methanol solvent. The advantage of this technique is the isolation of large amounts of curcumin (208 mg from 25 g turmeric rhizomes powder) with smaller quantity of methanol.
https://icc.journals.pnu.ac.ir/article_801_74504db55e20452699142f0a811ea3e0.pdf
2014-10-01
236
243
Keywords: turmeric
Currcuma longa L
curcumin
isolation
soxhlet extractor
Mehdi
Nabati
mnabati@ymail.com
1
Azarbaijan Shahid Madani University
LEAD_AUTHOR
Mehrdad
Mahkam
mehdi_1046@yahoo.com
2
Azarbaijan shahid madani university
AUTHOR
Hassan
Heidari
wiyoduck@yahoo.com
3
Azarbaijan Shahid Madani University
AUTHOR
[1] L.C. Price, R.W. Buescher, J. Food Sci., 1997, 62, 267-269.
1
[2] E.W.C. Chan, Y.Y. Lim, S.K. Wong, S.P. Tan, F.S.Lianto, M.Y. Yong, Food Chemistry.,2009, 113, 166–172.
2
[3] A.D. Dilman, P.A. Belyakov, A.A. Korlyukov, V.A. Tartakovsky, J. Tetrahedron letters., 2004, 45, 3741-3744.
3
[4] A. Kunwar, A. Barik, R. Pandey, K.I. Priyadarsini, Biochim. Biophys. Acta., 2006,1760, 1513-1520.
4
[5] B.K. Adams, E.M. Ferstl, M.C. Davis, M. Herold, S. Kurtkaya, R.F. Camalier, M.G. Hollingshead, G. Kaur, E.A. Sausville, F.R. Rickles, J.P. Snyder, D.C. Liotta, M. Shoji, Bioorg. Med. Chem., 2004, 12, 3871-3883.
5
[6] H. Ohtsu, Z.Y. Xiao, J. Ishida, M. Nagai, H.K. Wang, H. Itokawa, C.Y. Su, C. Shih, T.Y. Chiang, E. Chang, Y.F. Lee, M.Y. Tsai, C.S. Chang, K.H.J. Lee, Med. Chem., 2002, 45, 5037-5042.
6
[7] A. Mazumder, N. Neamati, S. Sunder, J. Schulz, H. Pertz, E. Eich, Y. Pommier, J. Med. Chem.,1997, 40, 3057-3063.
7
[8] S.Y. Han, Y.Q. Yang, Dyes and pigments, 2005, 64, 157-161.
8
[9] C.M. Ahn, B.G. Park, H.B. Woo, J. Ham, W.S. Shin, S. Lee, J. Bioorg. Med. Chem., 2009, 19, 1481-1483.
9
[10] W.Y. Shao, Y.N. Cao, Z.W. Yu, W.J. Pan, X. Qiu, X.Z Bu, L.K. An, Z.S. Huang, L.Q. Gu, A.S.C. Chan, J. Tetrahedron letters, 2006, 47, 4085-4089.
10
[11] M. Nabati, M. Mahkam, Iran. Chem. Commun., 2014, 2, 129-136.
11
[12] H.H. Tonnesen, J.Z.Karlsen, Lebensm. Unters. Forsch., 1985, 180, 132-134.
12
[13] H.H. Tonnesen, J.Z. Karlsen, Lebensm. Unters. Forsch., 1985, 180, 402-404.
13
[14] G.W. Schieffer, J. Liq. Chromatogr. Related Technol., 2002, 25, 3033-3044.
14
[15] M. Mahkam, M. Nabati, H.R. Kafshboran, Iran. Chem. Commun., 2014, 2, 172-178.
15
[16] M.A. Tomren, M. Másson, T. Loftsson, H.H. Tønnesen, Int. J. Pharm., 2007, 338, 27-34.
16
[17] F. Campbell, G.P. Collett, Future Oncology, 2005, 1, 405-414.
17
ORIGINAL_ARTICLE
DFT study of dimers of dimethyl sulfoxide in gas phase
Density functional (DFT) calculations at M05-2x/aug-cc-pVDZ level were used to analyze the interactions between dimethyl sulfoxide (DMSO) dimers. The structures obtained have been analyzed with the Atoms in Molecules (AIMs) and Natural Bond Orbital (NBO) methodologies. Four minima were located on the potential energy surface of the dimers. Three types of interactions are observed, CH•••O, CH•••S hydrogen bonds and orthogonal interaction between the lone pair of the oxygen with the electron-deficient region of the sulfur atom. Stabilization energies of dimers including BSSE and ZPE are in the range 27–40 kJ mol-1. The most stable conformers of dimers at DFT level is cyclic structure with antiparallel orientation of S=O groups that pairing with three C–H…O and a S…O interactions.
https://icc.journals.pnu.ac.ir/article_802_3089fa0b9326b33b6c52d38487a92bbe.pdf
2014-10-01
244
254
Hydrogen bonding
DMSO
DFT
dimers
Reza
Fazaeli
r_fazaeli@azad.ac.ir
1
Modeling and Optimization Research Center in Science and Engineering, South Tehran Branch, Islamic Azad University, Tehran, Iran, P.O. Box 11365-4435
AUTHOR
Mohammad
Solimannejad
m-solimannejad@araku.ac.ir
2
Department of Chemistry, Faculty of Sciences, Arak University, Arak 38156-8-8349, Iran
LEAD_AUTHOR
[1] G.A. Jeffrey. An introduction to hydrogen bonding. Oxford University Press, New York, 1997.
1
[2] S. Scheiner. Hydrogen bonding, Oxford University Press, New York, 1997.
2
[3] G.R. Desiraju, T. Steiner. The weak hydrogen bond, Oxford University Press, Oxford, 1999.
3
[4] S. Scheiner Ed., Molecular Interactions: From Van der Waals to Strong Bound Complexes, Wiley, Chichester, U.K, 1997.
4
[5] G.A. Jeffrey, W. Saenger. Hydrogen Bonding in Biological Structures, Springer-Verlag, Berlin, 1991.
5
[6] G.R. Desiraju, T. Steiner. The Weak Hydrogen Bond in Structural Chemistry and Biology, Oxford, New York, 1999.
6
[7] Y. Gu, T. Kar, S. Scheiner,THEOCHEM., 2000, 500, 441-452.
7
[8] S.J. Grabowski Ed. Hydrogen Bonding-New Insights, Springer, Dordrecht, 2006.
8
[9] T. Kar, S. Scheiner, J. Phys. Chem. A., 2004, 108, 9161-9168.
9
[10] G. Gilli, P. Gilli. The Nature of the Hydrogen Bond, Oxford University Press, Oxford, UK. 2009.
10
[11] Q. Li, H. Wang, Z. Liu, W. Li, J. Cheng, B. Gong, J. Sun, J. Phys. Chem. A., 2009, 113, 14156-14160.
11
[12] G. Orlova, S. Scheiner, J. Phys. Chem. A., 1998, 102, 4813-4818.
12
[13] B.G.D. Oliveira, MN. Ramos, Int. J. Quant. Chem., 2010, 110, 307-316.
13
[14] M. Nishio, Y. Umezawa, K. Honda, S. Tsuboyama , H, Suezawa, Cryst. Eng. Comm., 2009, 11, 1757-1788.
14
[15] S. Hammerum, J. Am. Chem. Soc., 2009, 131, 8627-8635.
15
[16] M. Solimannejad, Scheiner, Chem. Phys. Lett., 2006, 424, 1-6.
16
[17] S. Scheiner, J. Phys. Chem. B., 2009, 113, 10421-10427.
17
[18] S. Cybulski, S. Scheiner, J. Am. Chem. Soc., 1987, 109, 4199-4206.
18
[19] Z. Latajka, S. Scheiner, J. Comput. Chem., 1987, 5, 674-682.
19
[20] S. Scheiner, Theor. Chim. Acta., 1980, 57, 71-80.
20
[21] H.S. Biswal, S. Wategaonkar, J. Phys. Chem. A., 2009, 113, 12763-12773.
21
[22] R.F. Freitas, S.E. Galembeck, Chem. Phys. Lett., 2006, 423, 131-137.
22
[23] E.J. Cocinero, R. Sánchez, S. Blanco, A. Lesarri, JC. López, JL. Alonso, Chem. Phys. Lett., 2005, 402, 4-10.
23
[24] F.H. Allen, C.M. Bird, R.S. Rowland, P.R. Raithby, Acta. Cryst., 1997, B53, 680-695.
24
[25] F. Wennmohs, V. Staemmler, M. Schindler, J. Chem. Phys., 2003, 119, 3208-3218.
25
[26] M.W. Schmidt, K.K. Baldridge, J.A. Boatz, S.T. Elbert, M.S. Gordon, J.H. Jensen, S. Koseki, N. Matsunaga, K.A. Nguyen, S.J. Su, T.L. Windus, M. Dupuis, J.A. Montgomery, General atomic and molecular electronic structure system, J. Comput. Chem., 1993, 14, 1347−1363.
26
[27] Y. Zhao, N.E. Schultz, D.G. Truhlar, J. Chem. Theory. Comput., 2006, 2, 364-382.
27
[28] Y. Zhao, D.G. Truhlar, J. Chem. Theory. Comput., 2006, 2, 1009-1018 .
28
[29] S.F. Boys, F. Bernardi, Mol. Phys., 1970, 19, 553-566.
29
[30] R.F.W. Bader, Atoms in Molecules: A Quantum Theory. Clarendon Press, Oxford, 1990.
30
[31] F. Biegler-Konig, J. Schonbohm AIM 2000 Program Package, Ver.2.0, University of Applied Sciences, Bielefield, Germany, 2002.
31
[32] E.D. Glendening, J. Am. Chem. Soc., 1996, 118, 2473-2482.
32
[33] E.D. Glendening, J. Phys. Chem. A., 2005, 109, 11936-11940.
33
[34] F. Weinhold, CR. Landis, Valency and Bonding. A Natural Bond Orbital Donor–Acceptor Perspective, Cambridge Press, Cambridge, 2005.
34
[35] E.D Glendening, J.K Badenhoop, A.E Reed, J.E. Carpenter, J.A. Bohmann, C.M. Morales, F. Weinhold NBO 5.G, Theoretical Chemistry Institute, University of Wisconsin, Madison, WI, 2004.
35
[36] M.W. Schmidt , K.K. Baldridge, J.A. Boatz, S.T. Elbert, M.S. Gordon, J.H. Jensen, S. Koseki, N. Matsunaga, K.A. Nguyen, S.J. Su, T.L. Windus, M. Dupuis, J.A. Montgomery, J. Comput. Chem., 1993, 14, 1347-1363.
36
[37] W. Fader, H. Dreizler, H.D. Rudolph, V. Typke, Z. Naturforsch., 1969, 24A, 266-271.
37
[38] R. Paulini, K. Muller, F. Diederich, Angew. Chem. Int. Ed., 2005, 44, 1788-1805.
38
[39] G.P.A. Yap, F.A. Jove, R.M. Claramunt, D. Sanz, I. Alkorta, J. Elguero, Aus. J. Chem., 2005, 58, 817-822.
39
[40] M. Solimannejad, S. Massahi, I. Alkorta, Chem. Phys., 2009, 362, 1-7.
40
[41] I. Rozas, I. Alkorta, J. Elguero, J. Am. Chem. Soc., 2000, 122, 11154-11161.
41
[42] P. Lipkowski, S.J. Grabowski, J. Leszczynski, J. Phys. Chem. A., 2006, 110, 10296-10302.
42
[43] JG. Contreras, E.R. Johnson, S. Keinan, R. Chaudret, J.P. Piquemal, D.N. Beratan, W. Yang, J. Chem. Theory. Comput., 2011, 2011, 625-632.
43
[44] U. Onthog, T. Megyes, I. Bako, T. Radnai, T. Grosz, K. Hermansson, M. Probst, Phys. Chem. Chem. Phys., 2004, 6, 2136-2139.
44
[45] RM- Ibberson, Acta. Crystallogr., 2005, C61, o571-o573.
45
ORIGINAL_ARTICLE
Simple spectrophotometric methods for quantification of modafinil using 1,2-naphthoquinone-4-sulphonate and 2,4-dinitrophenol as analytical reagents
Two simple visible spectrophotometric methods are developed and validated for the quantification of modafinil using 1,2-naphthoquinone-4-sulphonic acid (NQS method) and 2,4-dinitrophenol (DNP method) as analytical reagents. The NQS method involves the reaction of modafinil with 1,2-naphthoquinone-4-sulphonate in alkaline medium at room conditions to form a yellow colored product exhibiting maximum absorption at 430 nm. DNP method is based on the proton transfer from 2,4-dinitrophenol to modafinil at room conditions and then we have the formation of yellow colored ion-pair complex exhibiting maximum absorption at 475 nm. Different variables affecting the reaction were studied and optimized. Under the optimized experimental conditions, Beer's law is obeyed in the concentration ranges of 10-100 and 8-60 μg/mL with the detection of limit values of 0.486 and 0.258 μg/mL for NQS method and DNP method, respectively The molar absorptivity and Sandell's sensitivity for both of the methods are reported. The methods were validated in terms of accuracy, precision and robustness. The results were satisfactory. The proposed methods were effectively applied to the analysis of the modafinil in their tablet formulations. The recoveries were 99.92% and 99.96% with RSD and 0.863% and 0.722% for NQS and DNS methods, respectively. The assay was not interfered by common excipients.
https://icc.journals.pnu.ac.ir/article_813_f244589af745d1ea314771fa96669b85.pdf
2014-10-01
255
268
Narcoleptic drug
naphthoquinone-4-sulphonic acid
dinitrophenol
Spectrophotometry
Analysis
Burla Sunitha
Seshamamba
sunithafst@gmail.com
1
Department of Biotechnology, Jagarlamudi Kuppuswamy Choudary College, Guntur, Andhra Pradesh-522006, India.
AUTHOR
Peruri Veera
Satyanarayana
sunitha_b2006@yahoo.com
2
Department of Biochemistry, Acharya Nagarjuna University, Guntur, Andhra Pradesh-522510, India.
AUTHOR
Chandra
Sekharan
balumphil@gmail.com
3
Department of Food Chemistry and Nutrition, College of Food Science and Technology, Bapatla, Andhra Pradesh-522101, India.
LEAD_AUTHOR
[1] P. Gerrard, R. Malcolm, Neuropsychiatr. Dis. Treat., 2007, 3, 349–364.
1
[2] T.E. Scammell, J. Matheson, Expert Opin. Investig. Drugs., 1998, 7, 99-112.
2
[3] A. Ivanenko, R. Tauman, D. Gozal, Sleep Med., 2003, 4, 579-582.
3
[4] J.W. Young, M.A. Geyer, Biol. Psychiatry., 2010, 67, 784–787. [5] J.L. Donovan, R.J. Malcolm, J.S. Markowitz, C.L. DeVane, Therap. Drug Monitor., 2003, 25, 197-202.
4
[6] G. Moachon, D. Matinier,J. Chromatogr. B Biomed. Appl., 1994, 654, 91-96.
5
[7] S.H. Gorman, J. Chromatogr. B Biomed. Sci. Appl., 1999, 730, 1-7.
6
[8] P. Burnat, F. Robles, B. Do, J. Chromatogr. B Biomed. Sci. Appl., 1998, 706, 295-304.
7
[9] T. Ji-Yuan, J. Nanhua University (Medical Edition), 2007, 6, 873-875.
8
[10] H.A. Schwertner, S.B. Kong,J. Pharm. Biomed. Anal.,2005, 37, 475-479.
9
[11] Y.L. Tseng, V. Uralets, C.T. Lin, F.H. Kuo, J. Pharm. Biomed. Anal., 2005, 39, 1042-1045.
10
[12] A.R. McKinney, C.J. Suann, A.M. Stenhouse, Rapid Commun. Mass. Sp., 2005, 19, 1217–1220. [13] V. Venkatesh, N. Vijaya Lakshmi, P. Venkata Suresh, P. Mohana rao, K. Siva, G. Dhana Raju, N. Rama Rao, J. Pharma. Res., 2011, 4, 509-512. [14] C. Narasimha, B. Raju, G.D. Rao, K. Swetha, Int. Cur. Pharm. J., 2012, 1, 77-80. [15] K. Swetha, S. Mohideen, T. Satyanarayana, C.H. Narasimha, P.S. Kumar, M. Shyamala, Int. J. Res. Pharm. Biomed. Sci., 2011, 2, 1837-1840. [16] R. Nageswara Rao, D.D. Shinde, M.V.N. Kumar Talluri, Talanta, 2007, 73, 407–414. [17] A.A. Khan, S.K. Panda, S.S. Kumar, D.A. Kumar, Int. J. Bio. Pharm. Res., 2011, 2, 39-44. [18] V. Chaudhary, M. Ubale, Int. J. Pharm. Chem. Sci., 2013, 2, 207-213. [19] G.P. Pandya, H.S. Joshi, IOSR J. Pharma. Bio. Sci., 2013, 5, 22-28.
11
[20]B. Fan, M. Geng, Y. Wang, Q. Li, J. Anal. Chem., 2013, 68, 965-968. [21] A.A. Elbashir, A.H.E. Elwagee, J. Asso. Arab Universities Basic Appl. Sci., 2012, 11, 32–36. [22] Q.M. Li, Z.J. Yang, Spectrochim. Acta. A Mol. Biomol. Spectrosc., 2007, 66, 656-661. [23] Q. Li, J. Li, Z. Yang, Anal. Chim. Acta., 2007, 583, 147-152.
12
[24] S.A. Abdulrahman, K. Basavaiah, Int. J. Anal. Chem., 2011, 2011, 619310. [25] M.A. Omar, D.M. Nagy, M.A. Hammad, A.A. Aly, J. Appl. Pharma. Sci., 2013, 3, 151-161. [26] Y. Li, Z. Yansheng, X. Chunsheng, W. Wenlong, J. Chinese Pharma. Sci., 2001, 10, 196-199. [27] H.A. Benesi, J. Hidelbrand, J. Am. Chem. Soc., 1949, 71, 2703-2707. [28] A.N. Martin, J. Swarbrick, A. Cammarata, Physical Pharmacy; 3rd ed., Lee& Febiger, Philadelphia: PA, 1969, pp. 344. [29] Validation of Analytical Procedures; Methodology, International Conference on Harmonization (ICH): Text and Methodology Q2 (R 1): Complementary Guideline on Methodology dated 06 November 1996: incorporated in November 2005, London.
13
ORIGINAL_ARTICLE
Synthesis and characterization of supramolecule self-assembly polyamidoamine (PAMAM) G1-G1 NH2, CO2H end group Megamer
Supramolecule self assembly polyamidoamine (PAMAM) dendrimer refers to the chemical systems made up of a discrete number of assembled molecular subunits or components. These strategies involve the covalent assembly of hierarchical components reactive monomers, branch cells or dendrons around atomic or molecular cores according to divergent/convergent dendritic branching principles, systematic filling of space around a core with shells (layers) of branch cells. The polydispersity index (PDI) for the Supramolecule megamer are pretty closed to one, are in agreement with the Poisson probability distribution. Polyamidoamine (PAMAM) dendrimer G1-G1 that it was PAMAM Megamer NH2, COOH end group synthesized and characterized by FT-IR, 1H NMR, 13C NMR spectra and Gel Permeation Chromatography (GPC).
https://icc.journals.pnu.ac.ir/article_821_9c5039d59271de0e179004a60f387096.pdf
2014-10-01
269
276
Supramolecule
Polyamidoamin
PAMAM Megamer
Self- assembly
Dendrimer
Omid
Louie
louie5556@gmail.com
1
Department of Chemistry, Payame Noor University, PO Box 19395-4697, Tehran, Iran
LEAD_AUTHOR
Abdoulhossien
Massoudi
massoudihossein@yahoo.com.au
2
Department of Chemistry, Payame Noor University, PO Box 19395-4697, Tehran, Iran
AUTHOR
Samaneh
Maghsoodi
sam.maghsoodi@yahoo.com
3
Department of Chemistry, Payame Noor University, PO Box 19395-4697, Tehran, Iran
AUTHOR
[1] W. Zeng, Z. Mao, J. Li, Zh. Hong, Sh. Qin, Journal of supramolecular chemistry, 2002, 2, 501-507.
1
[2] L.T. Piehler, J. Li, J. Qin, L.T. Baker, D.A. Tomalia, Langmuir, 2000, 16, 5613-5616.
2
[3] G.R. Newkome, C.D. Shreiner, Polymer, 2008, 49, 1-173.
3
[4] A. H. Massoudi, H. Vahedi, O. Louie, S. Sajjadifar, E-Journal of Chemistry, 2009, 6, 681-684.
4
[5] V. Percec, A.E. Dulcey, V.S.K. Balagarusamy, Y. Miura, J. Smidrkal, M. Peterca, S. Nummelin, U. Edlund, S.D. Hudson, P.A. Heiney, H. Duan, S.N. Magonov, Nature, 2004, 430, 764-768.
5
[6] L.L. Rossi, R.H. de Rossi, Journal of supramolecular chemistry, 2002, 2, 509-514.
6
[7] D. A. Tomalia, Prog. Polym. Sci. 2005, 30, 294–324.
7
[8] D. A. Tomalia, R. Esfand, L.T. Piehler, D.R. Swanson, S. Uppuluri, High Performance Polymers, 2001, 13, 154-156.
8
[9] M. Wood, Z. Kovacs, A.D. Sherry, Journal of supramolecular chemistry, 2002, 2, 1-5.
9
[10] Supramolecular Chemistry: From Molecules to Nanomaterials, P.A. Gale and J.W. Steed (Eds), Wiley (2012) ISBN 978-0-470-74640-0.
10
[11] O. Louie , A.H. Massoudi , H. Vahedi, S. Sajjadifar, H. Asadi, Journal of Scientific Research, 2013, 5, 103-105 (DOI: 10.4236/eng.2012.410B026 ).
11
[12] K. Dinakaran, I. Toyoko, Langmuir. 2009, 25, 5282–5285.
12
[13] O. Louie, A.H. Massoudi , H. Vahedi, S. Sajjadifar, Polymer, 2009, 50, 5605–5607.
13
[14] N. Bertrand, M.A. Gauthier, C. Bouvet, P. Moreau, A. Petitjean, J.C. Leroux, J. Leblond, Journal of Controlled Release, 2011, 155, 200-210.
14
[15] A.J. Khopade, H. Mouler, Macromolecular Rapid Communications, 2005, 26, 445-449.
15
[16] M. Sechi, F. Casu, I. Campesi, S. Fiori, A. Mariani, Molecules, 2006, 11, 968-977.
16
[17] D.A. Tomalia, New J. Chem., 2012, 36, 264-281.
17
[18] O. Louie, A. H. Massoudi, M. Atapour, M. Mojarad, R. Raoofian, F. Baghebani, M. Soujtanloo, H. Vahedi, Clinical Biochemistry, 2011, 44, S281-S282.
18
[19] O. Louie, A.H. Massoudi, A. Agah, Iranian Chemical Communication, 2013, 1, 13-17.
19
[20] G.A. Silva, C. Czeisler, K.L. Niece, E. Beniash, D.A. Harrington, J.A. Kessler, S.I. Stupp, Science, 2004, 303, 1352-1355.
20
[21] V. Percec, M. Glodde, T.K. Bera, I. Shiyanovskaya, K.D. Singer, V.S.K. Balagarusamy, P.A. Heiney, I. Schnell, A. Rapp, H.W. Spiess, S.D. Hudson & H. Duan, Nature, 2002, 419, 384-387.
21
ORIGINAL_ARTICLE
Isolation and structure elucidation of coumarin and cinamate derivatives from Lycium ruthenicum
Lycium species is a popular medicinal plant in the traditional Chinese medicine and Lycium ruthenicum is a native medicinal plant of Iran. Lycium genus has several biologically important properties too. Investigation of chemical composition of ethyl acetate extract of this plant is the goal of this study. Two coumarins (Scopoletin and Sculetin) and Methyl-2-hydroxy-4-undecanoxy-trans-cinamate were isolated and characterized as the major constituents using 1H-NMR, 13C-NMR and FT- IR spectroscopic data, MS spectrometry, elemental analysis and by comparison with the literature values. Phytochemical investigation of Lycium ruthenicum demonstrated the presence of important biologically active compounds. This is the first phytochemical study of this species in Iran.
https://icc.journals.pnu.ac.ir/article_826_5cd210ec22d52ccfbaa407a6158adab8.pdf
2014-10-01
277
282
Lycium ruthenicum
traditional medicine
phytochemistry
coumarine
Scopoletin
Esculetin
Hassan
Valizadeh
h-valizadeh@azaruniv.edu
1
Department of Chemistry, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
LEAD_AUTHOR
Fatemeh
Mahmoodi Kordi
mahmoudi@azaruniv.edu
2
Department of Biology, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
AUTHOR
Reza
Koohkan
koohkanreza@ymail.com
3
Department of Chemistry, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
AUTHOR
Mir Babak
Bahadori
mb.bahadori@mrgums.ac.ir
4
Department of Chemistry, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran
AUTHOR
Mehdi
Moridi Farimani
m_moridi@sbu.ac.ir
5
Department of phytochemistry, Shahid Beheshti University, Tehran, Iran
AUTHOR
[1] Z. Shan, Z. Xian, Y. Webbing, N. Yuge, G. Xiangdong, Carbohyd Polym., 2010, 80, 1161-1167.
1
[2] A.M. Clark, Pharm. Res., 1996, 3, 1133-1144.
2
[3] D.J. Phillipson, Phytochem., 2007, 68, 2960-2972.
3
[4] R.A. Levin, J.S. Miller, Am. J. Bot., 2005, 92, 2044-2053.
4
[5]A.M. Venter, Ph.D. Dissertation, University of the Orange Free State, Bloemfontein, South Africa, 2000.
5
[6] J.S. Miller, D.L. Venable, Am. J. Bot., 2002, 89, 1907-1915.
6
[7] Z. Shan, Z. Xian, Y. Webbing, N. Yuge, Carbohyd Polym., 2010, 80, 1161-1167.
7
[8] A. Harunobu, R.F. Norman, Food Res Int., 2011, 44, 1702-1717.
8
[9] B.K. Cuia, C. Yan, S. Lund, J. Wang, S.H. Li, Q.B. Wang, S.P. Li, M.S. Chen, X.J. Lin, Int. J. Biol. Macromol, 2012, 51, 314-318.
9
[10] D.G. Lee, Y.K. Park, M.R. Kim, H.J. Jung, Y.B. Seu, K.S. Hahm, E.R. Woo, Biotech. Lett., 2004, 26, 1125-1130.
10
[11] I. Dahech, W. Farah, M. Trigui, A.B. Hssouna, H. Belghith, K.S. Belghith, F.B. Abdallah, Int. J. Biol. Macromol, 2013, 60, 328-333.
11
[12] H. Amagase, N.R. Farnsworth, Food Res Int., 2011, 44, 1702–1717.
12
[13] A. Harunobu, S. Buxiang, B. Carmia, Nut Res., 2009, 29, 19–25.
13
[14] M. Adams, M. Wiedenmann, G. Tittel, R. Bauer, Phytochem Anal, 2006, 17, 279-285.
14
[15] S.Y. Kim, K.H. Lee, K.S. Chang, J.Y. Bock, M.Y. Jung, Food Chem., 1997, 58, 297-303.
15
[16] J. Bruneton Pharmacognosy, Phytochemistry, Medicinal Plants. Second Edition, Hampshire, UK, Intercept Ltd, 1999, pp. 263-277.
16
[17] R.D.H. Murray, Prog. Chem. Org. Nat. Prod., 1991, 58, 338-343.
17
[18] M. Selim. Chem. Abs., 1992, 27, 811-819.
18
[19] R.D.H. Murray, J. Mendez, SA. Brown, The natural coumarins: Occurance, chemistry and biochemistry. New York, John Wiley & Sons, 1982, p. 21.
19
[20] M. Zahradnik, The production and application of fluorescent brightening agents. New York, John Wiley & Sons, 1992, p. 164.
20
ORIGINAL_ARTICLE
QSRR models of veterinary drugs in milk in ultra-performance liquid chromatography coupled to time of flight mass spectrometry
The veterinary drugs residues are also important pollutants found in milk, since veterinary drugs are commonly used in cattle management. Considering the role of milk in human nutrition and its wide consumption throughout the world, it is very important to ensure the milk quality. A quantitative structure–retention relationship (QSRR) was developed using the partial least square (PLS), Kernel PLS (KPLS) and Levenberg-Marquardt artificial neural network (L-M ANN) approach for chemometrics study. Genetic algorithm was employed as a factor selection procedure for PLS and KPLS modeling methods. By comparing the results, GA-KPLS descriptors are selected for L-M ANN. Finally a model with a low prediction error and a good correlation coefficient was obtained by L-M ANN. This is the first research on the QSRR of veterinary drugs using the chemometrics models.
https://icc.journals.pnu.ac.ir/article_831_7f2404c98650143656c473c4b1a7bcf7.pdf
2014-10-01
283
299
Veterinary drugs
Milk
UPLC
TOFMS
Correlation coefficient
QSRR
Hadi
Noorizadeh
hadinoorizadeh@yahoo.com
1
Department of Chemistry, Payame Noor University of ilam, Ilam, Iran
LEAD_AUTHOR
Sharmin
Esmaeilpoor
esmaeilpoor@yahoo.com
2
Department of Chemistry, Payame Noor University, P.O. BOX 19395-4697 , Tehran, Iran
AUTHOR
Zohreh
Moghadam
moghadam.z@yahoo.com
3
Department of Chemistry, Payame Noor University, P.O. BOX 19395-4697 , Tehran, Iran
AUTHOR
Shahnaz
Nosratolahy
nosratolahy@yahoo.com
4
Education Ilam, Fazilat Girls High School
AUTHOR
[1] A.A.M. Stolker, U.A.Th. Brinkman, J. Chromatogr. A, 2005, 1067, 15-24.
1
[2] H.P. Tang, C. Ho, S.S.L. Lai, Rapid Commun. Mass Spectrom, 2006, 20, 2565-2572.
2
[3] European Parliament and the Council of the European Union. Commission Regulation No 124/2009 of 10 February 2009 setting maximum levels for the presence of coccidiostats or histomonostats in food resulting from the unavoidable carry-over of these substances in non-target feed. L 40.
3
[4] European Parliament and the Council of the European Union. Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. L 15.
4
[5] S.L. Stead, H. Ashwin, S.F. Richmond, M. Sharman, P.C. Langeveld, Int. Dairy J, 2008, 18, 3–11.
5
[6] D. L. Borneman, S. Ingham, Food Polic, 2014, 46, 150-156.
6
[7] P. Anttila, T. Hyötyläinen, A. Heikkilä, M. Jussila, J. Finell, M. Kulmala, M.-L. Riekkola, J. Sep. Sci., 2005, 28, 337-348.
7
[8] J. Pol, B. Hohnova, M. Jussila, T. Hyotylainen, J. Chromatogr. A, 2006, 1130, 64-75.
8
[9] B.G. Knecht, A. Strasser, R. Dietrich, E. Märtlbauer, R. Niessner, M.G.Weller, Anal. Chem, 2004, 76, 646-653.
9
[10] J. Lamar, M. Petz, Analytica Chimica Acta, 2007, 586, 296-309.
10
[11] G. Balizs, A. Hewitt, Analytica Chimica Acta, 2003, 492, 105-116.
11
[12] F.J. Lara, A.M. García-Campana, F. Alés-Barrero, J.M. Bosque-Sendra, L.E. GarcíaAyuso, Anal. Chem., 2006, 78, 7665-7673.
12
[13] M.A. García-Mayor, R.M. Garcinu˜no, P. Fernández-Hernando, J.S. Durand-Alegría, J. Chromatogr. A, 2006, 1122, 76-89.
13
[14] E.A. Christodoulou, V.F. Samanidou, J. Sep. Sci., 2007, 30, 2421-2429.
14
[15] R.C. Rodríguez-Díaz, J.M. Fernández-Romero, M.P. Aguilar-Caballos, A. Gómez-Hens, J. Agric. Food Chem., 2006, 54, 9670-9678.
15
[16] N.A. Karaseva, T.N. Ermolaeva, Talanta, 2014, 120, 312-317.
16
[17] Y. Zhou, Sh. X Huang, J.X. Pu, J. R Li, L. Sh. Ding, D. F. Chen, J. Pharm. Biomed. Anal., 2011, 56, 916– 927.
17
[18] G. Mirivel, V. Riffault, J. Galloo, J. Chromatogr. A, 2009, 1216, 6481–6489.
18
[19] G. Du, H.Y. Zhao, Q.W. Zhang, G.H. Li, F.Q. Yang, Y. Wang, Y.C. Li, Y.T. Wang, J. Chromatogr. A, 2010, 1217, 705–714.
19
[20] P. R. Duchowicz, M. A. Giraudo, E. A. Castro, A. B. Pomilio, Chem. Intell. Lab. Sys., 2011, 107, 384-390.
20
[21] M. Goodarzi, T. Chen, M. P. Freitas, Chem. Intell. Lab. Sys., 2010, 104, 260-264.
21
[22] T. Liu, I.A. Nicholls, T. Öberg, Analytica Chimica Acta, 2011, 702, 37-44.
22
[23] R. Kaliszan, P. Wiczling, M. J. Markuszewski, M.A. Al-Haj, J. Chromatogr. A, 2011, 1218, 5120-5130.
23
[24] C.I. De Matteis, D. A. Simpson, S. W. Doughty, M. R. Euerby, P. Nicholas Shaw, D. A. Barrett, J. Chromatogr. A, 2010, 1217, 6987-6993.
24
[25] K. Héberger, I. G. Zenkevich, J. Chromatogr. A, 2010, 1217, 2895-2902.
25
[26] A. A. D’Archivio, A. Incani, F. Ruggieri, J. Chromatogr. A, 2011, 13, 456-467.
26
[27] R. Todeschini, V. Consonni, A. Mauri, M. Pavan, DRAGON-Software for the calculation of molecular descriptors; Version 3.0 for Windows, 2003.
27
[28] D. Ortelli, E. Cognard, Ph. Jan, P. Edder, J. Chromatogr. B, 2009, 877, 2363–2374.
28
[29] E. Sarıpınar, N. Geçen, K. Şahin, E. Yanmaz, Euro. J. Med. Chem., 2010, 45, 4157-4168.
29
[30] S. Sagrado, M.T.D. Cronin, Analytica Chimica Acta, 2008, 609, 169-174.
30
[31] E. A. Hernández-Caraballo, F. Rivas, A.G. Pérez, L.M. Marcó-Parra, Analytica Chimica Acta, 2005, 533, 161-168.
31
[32] V. K. Gupta, H. Khani, B. Ahmadi-Roudi, Sh. Mirakhorli, E. Fereyduni, Sh. Agarwal, Talanta, 2011, 83, 1014-1022.
32
[33] T. Bolanča, Š. Cerjan-Stefanović, M. Regelja, H. Regelja, S. Lončarić, J. Chromatogr. A, 2005, 1085, 74-85.
33
[34] M. Arab Chamjangali, M. Beglari, G. Bagherian, J. Molecul. Graph. Model, 2007, 26, 360-367.
34
[35] R. Jia, Zh. Mao, Y. Chang, Sh. Zhang, Chem. Intell. Lab. Sys., 2010, 100, 91-98.
35
[36] M. Jalali-Heravi, A. Kyani, Euro. J. Med. Chem., 2007, 42, 649-659.
36
[37] H. Noorizadeh, M. Noorizadeh, Med Chem. Res., 2011, 18, 324-337.
37
[38] H. Chen, Analytica Chimica Acta, 2008, 609, 24–36.
38
[39] O. Deeb, Chem. Intell. Lab. Sys., 2010, 104, 181-194.
39
[40] Validation of Analytical Procedures; Methodology, International Conference on Harmonization (ICH): Text and Methodology Q2 (R1): Complementary Guideline on Methodology dated 06 November 1996: incorporated in November 2005, London.
40
ORIGINAL_ARTICLE
Pharmacological properties of some 3-substituted indole derivatives, a concise overview
Indole is a nitrogen-containing heterocycle. It is a very important motif in agriculture and pharmacy. Many compounds containing indole moiety has been isolated form nature. It is also an important part in natural alkaloids. Tryptophan is an amino acid which posses indole. 3-Sustituted indoles are the main group of its derivatives. Because the wide-spread application of 3-substituted indolic compounds their synthetic procedures are in demand by organic chemists. In this review we have focused on about twenty compound of 3-substituted indole derivatives that showed pharmacological properties. A concise synthetic route for some of them has also been reported. The main pharmaceutical properties of these compounds are antibacterial, anticancer and antimicrobial activities.
https://icc.journals.pnu.ac.ir/article_832_c7f6dcea50a9ba9c396b9f15fd5cd9ef.pdf
2014-10-01
300
315
indole
indolyl
pharmacy
drug
Synthesis
Kobra
Nikoofar
kobranikoofar@yahoo.com
1
chemistry department, school of sciences, alzahra university, vanak, tehran, i.t.iran
LEAD_AUTHOR
Diba
Kadivar
diba.kadivar@yahoo.com
2
Department of Chemistry, School of Science, Alzahra University, Vanak, Tehran 1993891176, Iran
AUTHOR
Samaneh
Shirzadnia
nikoofar.chem@gmail.com
3
Department of Chemistry, School of Science, Alzahra University, Vanak, Tehran 1993891176, Iran
AUTHOR
[1] P. Sreejith, R.S. Beyo, L. Divya, A.S. Vijayasree, M. Manju, O.V. Oommen, Indian J. Biochem. Biophys., 2007, 44, 164-168.
1
[2] Y. Nozaki, C. Tanford, J. Biol. Chem., 1971, 246, 2211-2217.
2
[3] J. Hajicek, Czech. Chem. Commun., 2007, 72, 821–898.
3
[4] M.A. Metwally, S. Shaaban, B.F. Abdel-Wahab, G.A. El-Hiti, Curr. Org. Chem., 2009, 13, 1475–1496.
4
[5] S. Agarwal, S. Cammerer, S. Filali, W. Frohner, J. Knoll, M.P. Krahl, K.R. Reddy, H.J. Knolker, Curr. Org. Chem., 2005, 9, 1601–1614.
5
[6] M.A.A. Radwan, E.A. Ragab, N.M. Sabry, S.M. El-Shenawy, Bioorg. Med. Chem., 2007, 15, 3832-3841.
6
[7] J.S. Yadav, B.V.S. Reddy, G. Narasimhulu, N.S. Reddy, P.N. Reddy, K.V. Purnima, P. Naresh, B. Jagadeesh, Tetrahedron Lett., 2010, 51, 244-247.
7
[8] P. Wu, Y. Wan, J. Cai, Synlett, 2008, 1193-1198.
8
[9] B.B. Aggarwal, H. Ichikawa, Cell Cycle, 2005, 4, 1201–1215.
9
[10] J.T. Tsai, H.C. Liu, Y.H. Chen, Mediators Inflamm., 2010, 2936–2942.
10
[11] G. Hongjing, Ch. Changgui, Z. Lihua, C. Changping, G. Yuanyuan, F. Mingyue, L.Wang, Q. Tang, J. Nut. Biochem., 2013, 24, 62-69.
11
[12] J.R. Weng, C.H. Tsai, S.K. Kulp, C.S. Chen, Cancer Lett., 2008, 262, 153-163.
12
[13] J.C. Hsu, A. Dev, A. Wing, C.T. Brew, L.F. Bjeldanes, G.L. Firestone, Biochem. Pharmacol., 2006, 72, 1714-1723.
13
[14] M. Saegusa, M. Hashimura, T. Kuwata, M. Hamano, I. Okayasu, Int. J. Cancer, 2006, 119, 2294-2303.
14
[15] H.P. Chang, M.L. Wang, M.H. Chan, Y. Sh. Chiu, Y.H. Chen, Nutrition, 2011, 27, 463-470.
15
[16] S. Samchai, P. Seephonkai, Ch. Kaewtong, Chinese J. Nat. Medicines, 2011, 9, 173-175.
16
[17] H.S. Kang, J.H. Choi, W.K. Cho, Arch. Pharm. Res., 2004, 27, 742-750.
17
[18] S.H. Kim, Y.S. Song, S.K. Kim, J. Ethnopharmacol., 2004, 93, 141-146.
18
[19] M. Prashad, L.L. Vecchia, K. Prasad, Synth. Commun., 1995, 25, 95-100.
19
[20] M. Shiri, M.A. Zolfigol, H.G. Kruger, Z. Tanbakouchian, Chem. Rev., 2010,
20
110, 2250–2293.
21
[21] K.W. Rahman, Y. Li, Z. Wang, S.H. Sarkar, F.H. Sarkar, Cancer Res., 2006, 66, 4952-4960.
22
[22] C. Hong, G.L. Firestone, L.F. Bjeldanes, Biochem. Pharmacol., 2002, 63, 1085–1097.
23
[23] A. Pouilhès, C. Kouklovsky, Y. Langlois, J.-P. Baltaze, S. Vispé, J.-P. Annereau, J.-M. Barret, A. Kruczynskic, C. Bailly, Bioorg. Med. Chem. Lett., 2008, 18, 1212–1216.
24
[24] E.A. Tsavkelova, T.A. Cherdyntseva, S.G. Botina, A.I. Netrusov, Microbiol. Res., 2007, 162, 69–76.
25
[25] Md. Mujahid, Ch. Sasikala, Ch.V. Ramana, Appl. Microbiol. Biotechnol., 2011, 89, 1001-1008.
26
[26] H. Gamal-Eldin, K. Elbanna, Curr. Microbiol., 2011, 62, 391-395.
27
[27] D. Brewer, W. Jerram, A. Taylor, Can. J. Microbiol., 1968, 14, 861-866.
28
[28] S. Sekita, Chem. Pharm. Bull., 1983, 31, 2998-3001.
29
[29] A. Kaji, R. Saito, Y. Hata, N. Kiriyama, Chem. Pharm. Bull., 1999, 47, 77-82.
30
[30] A. Kaji, T. Iwata, N. Kiriyama, S. Wakusawa, K. Miyamoto, Chem. Pharm. Bull., 1994, 42, 1682-1684.
31
[31] K.A. Alvi, H. Pu, M. Luche, A. Rice, H. App, G. McMahon, H. Dare B., Margolis, J. Antibiot., 1999, 52, 215-223.
32
[32] B. Zhang, G. Salituro, D. Szalkowski, Z. Li, Y. Zhang, I. Royo, D. Vilella, M.T. Diez, F. Pelaez, C. Ruby, R. L. Kendall, X. Mao, P. Griffin, J. Calaycay, J.R. Zierath, J.V. Heck, R.G. Smith, D.E. Moller, Science, 1999, 284, 974-977.
33
[33] P. Singh, P. Verma, B. Yadav, S.S. Komath, Bioorg. Med. Chem. Lett., 2011, 21, 3367-3372.
34
[34] M. Mazzei, E. Nieddu, M. Miele, A. Balbi, M. Ferrone, M. Fermeglia, M.T. Mazzei, S. Pricl, P. La Colla, F. Marongiu, C. Ibba, R. Loddo, Bioorg. Med. Chem., 2008, 16, 2591-2605.
35
[35] M.S. Estevão, L.C. Carvalho, D. Ribeiro, D. Couto, M. Freitas, A. Gomes, L.M. Ferreira, E. Fernandes, M. Manuel, B. Marques, Eur. J. Med. Chem., 2010, 45, 4869-4878.
36
[36] B.V. Subba Reddy, N. Rajeswari, M. Sarangapani, G. Roopa Reddy, Ch. Madan, K. Pranay Kumar, M. Srinivasa Rao, Bioorg. Med. Chem. Lett., 2011, 21, 6510-6514.
37
[37] M.E. Linday, Practical Introduction to Microbiology, London, E. & F. N. Spon Ltd United Kingdom, 1962.
38
[38] S.-K. Choi, D. Green, A. Ho, U. Klein, D. Marquess, R. Taylor, S.D. Turner, J.
39
Med. Chem., 2008, 51, 3609-3616.
40
[39] J.L. Collins, B.G. Shearer, J.A. Oplinger, S. Lee, E.P. Garvey, M. Salter, C. Duffy, T.C. Burnette, E.S. Furfine, J. Med. Chem., 1998, 41, 2858-2871.
41
[40] S.C. Annedi, Sh.P. Maddaford, J. Ramnauth, P. Renton, J. Speed, Suman Rakhit ,J.S. Andrews, F. Porreca, Bioorg. Med. Chem. Lett., 2012, 22, 1980–1984.
42
[41] R.B. Silverman, Acc. Chem. Res., 2009, 42, 439- 451.
43
[42] R.J. Sundberg, The Chemistry of Indoles,Academic: New York, NY, 1996.
44
[43] M.M. Ahmed, M.B. El-Saghier, B.K. Naili, N.A. Rammash, M. Saleh Khaled,
45
Arkivoc, 2007, xvi, 83-91.
46
[44] R. Tilak, K.B. Richa, K.S. Rakesh, G. Vivek, S. Deepak, P.S.I. Mohan, Eur. J. Med. Chem., 2009, 44, 3209-3216.
47
[45] C. Cinzia, D. Nicoletta, Bioorg. Med. Chem., 2010, 18, 6480-6488.
48
[46] R. Hossein nia, M. Mamaghani, Kh. Tabatabaeian, F. Shirini, M. Rassa, Bioorg. Med. Chem. Lett., 2012, 22, 5956–5960.
49
[47] M. Giampieri, A. Balbi, M. Mazzei, PLa Colla,C. Ibba, R. Loddo, Antiviral Res., 2009, 83, 179-185.
50
[48] R. Quirion, W.D. Bowen, Y. Itzhak, J.L. Jumien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam, D.P. Taylor, Trends Pharmacol. Exp. Ther., 1992, 13, 85-86.
51
[49] B. Bourrie, E. Bribes, J.M. Derocq, H. Vidal, P. Casellas, Curr. Opin. Invest. Drugs, 2004, 5, 1158-1163.
52
[50] T. Maurice, T.P. Su, Pharmacol. Ther., 2009, 124, 195-206.
53
[51] U. Jacquemard, S. Routier, N. Dias, A. Lansiaux, J.F. Goossens, C. Bailly, J.Y. Merour, Eur. J. Med. Chem., 2005, 40, 1087-1095.
54
[52] M.R. Buemi, L. De Luca, A. Chimirri, S. Ferro, R. Gitto, J. Alvarez-Buill, R. Alajarin, Bioorg. Med. Chem., 2013, 21, 4575-4580.
55
[53] H. Kumar, H.W. Lim, S.V. More, B.W. Kim, S. Koppula, I.S. Kim, D.K. Choi, Int. J. Mol. Sci., 2012, 13, 10478-10540.
56
[54] M. Serra, P. Madau, M.F. Chessa, M. Caddeo, E. Sanna, G. Trapani, M. Franco, G. Liso, R.H. Purdy, M.L. Barbaccia, G.B. Bigio, J. Pharmacol., 1999, 127,177- 182.
57
[55] R.M. Mohareb, H.H. Ahmed, G.A. Elmegeed., M.M. Abd-Elhalim, R.W. Shafic, Bioorg. Med. Chem., 2011, 19, 2966–2974.
58
[56] N.V. Lakshmi, P. Thirumurugan, K.M. Noorulla, P.T. Perumal, Bioorg. Med. Chem. Lett., 2010, 20, 5054–5061.
59
[57] Y. Peng, Zh. Zhao, X.Liu, G. Li, Res. Chem. Intermed., 2013, 39, 1897-1905.
60
[58] J.L. Mi, C.H. Zhou, X. Bai, Chin. J. Antibiot., 2007, 32, 587-593.
61
[59] J.L. Mi, J. Wu, C.H. Zhou, West Chin. J. Pharm. Sci., 2008, 23, 84-86.
62
[60] R. Pingaew, S. Prachayasittikul, S. Ruchirawat, V. Prachayasittikul, Mol. Divers., 2013, 17, 595-604.
63
[61] R. Gupta, A. Jain, R. Joshi, M. Jain, Bull. Korean Chem. Soc., 2011, 32, 899-904.
64
ORIGINAL_ARTICLE
Characterization of intermolecular interaction between Cl2 and HX (X=F, Cl and Br): An ab initio, DFT, NBO and AIM study
The character of the intermolecular interactions in Cl2-HX (X =F, Cl and Br) complexes has been investigated by means of the second-order Möller–Plesset perturbation theory (MP2) and the density functional theory (DFT) calculations. The results show that there are two types of lowest interaction potential equilibrium structures in the interactions between Cl2 and HX: X∙∙∙Cl type geometry and hydrogen-bonded geometry. The calculated interaction energies show that the X∙∙∙Cl type structures are more stable than the corresponding hydrogen-bonded structures. The nature of the intermolecular interactions has been also investigated by natural bond orbital (NBO) and atoms in molecules (AIM). The AIM analysis reveals that both types of intermolecular interactions are “closed-shell” noncovalent interactions.
https://icc.journals.pnu.ac.ir/article_833_bd94bedb2d39bff8351d1968302bc58d.pdf
2014-10-01
316
325
Intermolecular interaction
Halogen bond
DFT
MP2
NBO
AIM
Morteza
Vatanparast
mvatanparast@yahoo.com
1
Department of Physical Chemistry, University of Tabriz, Tabriz, Iran
LEAD_AUTHOR
Nabi
Javadi
nabi250@gmail.com
2
Department of Chemistry, Kharazmi (Tarbiat Moallem) University, Tehran, Iran
AUTHOR
Rasoul
Pourtaghavi Talemi
rasoulpourtaghavitalemi@yahoo.com
3
Department of Chemistry, Kharazmi (Tarbiat Moallem) University, Tehran, Iran
AUTHOR
Elahe
Parvini
e.parvini597@gmail.com
4
Department of Physical Chemistry, University of Tabriz, Tabriz, Iran
AUTHOR
[1] D. Philp, J.F. Stoddart, Angew. Chem. Int. Ed. Engl., 1996, 35, 1154-1196.
1
[2] J. Cerny, P. Hobza, Phys. Chem. Chem. Phys., 2007, 9, 5291-5303.
2
[3] S.J. Grabowski, Chem. Rev., 2011, 111, 2597-2625.
3
[4] G.R. Desiraju, T. Steiner, The Weak Hydrogen Bond: In Structural Chemistry and Biology, Oxford University Press, 2001.
4
[5] S.J. Grabowski, Hydrogen Bonding: New Insights, Springer London, Limited, 2006.
5
[6] T.M. Krygowski, J.E. Zachara-Horeglad, M. Palusiak, J. Org. Chem., 2010, 75, 4944-4949.
6
[7] P. Politzer, J. Murray, M. Concha, J. Mol. Model., 2007, 13, 643-650.
7
[8] K.E. Riley, J.S. Murray, P. Politzer, M.C. Concha, P. Hobza, J. Chem. Theory Comput., 2008, 5, 155-163.
8
[9] P. Politzer, P. Lane, M. Concha, Y. Ma, J. Murray, J. Mol. Model., 2007, 13, 305-311.
9
[10] P. Politzer, J.S. Murray, T. Clark, Phys. Chem. Chem. Phys., 2010, 12, 7748-7757.
10
[11] Y. Jiang, A.A. Alcaraz, J.-M. Chen, H. Kobayashi, Y.J. Lu, J.P. Snyder, J. Med. Chem., 2006, 49, 1891-1899.
11
[12] M.L. López-Rodríguez, M. Murcia, B. Benhamú, A. Viso, M. Campillo, L. Pardo, J. Med. Chem., 2002, 45, 4806-4815.
12
[13] H. Zhuo, M. Liu, Q. Li, W. Li, J. Cheng, Spectrochim. Acta, Part A, 2014, 127, 10-15.
13
[14] M. Domagała, P. Matczak, M. Palusiak, Comput. Theor. Chem., 2012, 998, 26-33.
14
[15] J. Wu, J. Zhang, Z. Wang, W. Cao, Int. J. Quantum Chem., 2007, 107, 1897-1906.
15
[16] J. Wu, J. Zhang, Z. Wang, W. Cao, J. Chem. Theory Comput., 2006, 3, 95-102.
16
[17] B. Jing, Q. Li, R. Li, B. Gong, Z. Liu, W. Li, J. Cheng, J. Sun, Comput. Theor. Chem., 2011, 963, 417-421.
17
[18] X. Liu, J. Cheng, Q. Li, W. Li, Spectrochim. Acta, Part A, 2013, 101, 172-177.
18
[19] W. Wu, Y. Lu, Y. Liu, H. Li, C. Peng, H. Liu, W. Zhu, Chem. Phys. Lett., 2013, 582, 49-55.
19
[20] A.E. Reed, L.A. Curtiss, F. Weinhold, Chem. Rev., 1988, 88, 899-926.
20
[21] R.F.W. Bader, Atoms in Molecules. A Quantum Theory, Clarendon Press, Oxford, UK, 1990.
21
[22] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, A. Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople, Gaussian 03, Revision B.03, Gaussian, Inc., Pittsburgh PA, 2003.
22
[23] A.D. Becke, J. Chem. Phys., 1993, 98, 5648-5652.
23
[24] C. Lee, W. Yang, R.G. Parr, Phys. Rev. B, 1988, 37, 785-789.
24
[25] W.J. Hehre, Ab initio molecular orbital theory, Wiley, 1986.
25
[26] S.F. Boys, F. Bernardi, Mol. Phys., 1970, 19, 553-566.
26
[27] E.D. Glendening, A.E. Reed, J.E. Carpenter, F. Weinhold, NBO Version 3.1.
27
[28] F.W. Biegler Konig, J. Schonbohm, D. Bayles, J. Comput. Chem., 2001, 22, 545-559.
28
[29] M. Ziółkowski, S.J. Grabowski, J. Leszczynski, J. Phys. Chem. A, 2006, 110, 6514-6521.
29